Skip to content

Stabilizing Mandibular Overdentures With a Single Implant Placed in the Canine Region of the Preferred Chewing Side

Stabilizing Mandibular Overdentures With a Single Implant Placed in the Canine Region of the Preferred Chewing Side Compared to the Midline Single-implant Overdenture Treatment Concept: an RCT With 5 Years of Follow-up

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06755034
Acronym
c-SIMO
Enrollment
36
Registered
2025-01-01
Start date
2025-01-01
Completion date
2031-12-31
Last updated
2025-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Completely Edentulous Patients

Brief summary

The investigators are evaluating the use of a single implant to stabilize complete dentures in the lower jaw, in the canine region of the preferred chewing side. They are conducting this study to determine whether this treatment concept gives satisfactory results, and how it compares with the standard position in the center of the lower jaw.

Interventions

DEVICEc-SIMO

Placement of an implant in the mandibular canine area and using it to stabilize a pre-existing mandibular complete denture.

DEVICEm-SIMO

Placement of an implant in the midline of the mandible and using it to stabilize a pre-existing mandibular complete denture.

Sponsors

Frauke Müller
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Informed consent signed by the subject * Age ≥ 60 years * Edentulous and wearing sufficient complete maxillary and mandibular dentures or ones that can be rendered sufficient via a reline and/or renewal of the prosthetic teeth * Healed edentulous mandible (minimum 6-8 weeks since last extraction in the anterior zone (4-4) and one year in the posterior zone (5-8)) * Physical status ASA1 and ASA2

Exclusion criteria

* Contraindications to the medical devices used, e.g. known hypersensitivity or allergy * Vulnerable subjects * Enrollment of the investigator, his/her family members, employees and other dependent persons * Known or suspected non-compliance, drug or alcohol abuse * Inability to perform adequate oral hygiene * Inability to follow the procedures of the investigation, e.g. due to language problems, psychological disorders, dementia, Parkinson etc. of the subject (Dementia: clock-drawing test score ≤ 5) * Surgical risk factors such as, but not limited to, uncontrolled diabetes, immunosuppression, radiation, chemotherapy, or antiresorptive medication (ex. Bisphosphonates) * Heavy smoking habit: \>20 cig/d * Reported severe bruxism or clenching habits, clinically present oro-facial pain * Depression: Geriatric Depression Scale \> 9 * Xerostomia: SSFR ≤ 0.7ml/min * Ridge dimensions \<6 mm (width) by 10 mm (height) in the canine or midline area * Ridge defects requiring bone augmentation procedures

Design outcomes

Primary

MeasureTime frameDescription
OHIP-EDENTFrom baseline to 5-year follow-upOral health-related quality of life questionnaire
DSIFrom baseline to 5-year follow-upDenture Satisfaction Index (questionnaire)

Secondary

MeasureTime frameDescription
Occlusal analysisFrom baseline to 5-year follow-upDental Prescale System
Plaque indexFrom implant loading to 5-year follow-upmodified Plaque Index (modPI)
Bleeding on probingFrom implant loading to 5-year follow-upmodified Bleeding Index (modBI)
Preferred chewing sideFrom baseline to 5-year follow-upAsymmetry Index
Keratinized peri-implant tissuesFrom implant loading to 5-year follow-upMeasurement of the keratinized tissue around implants
Prosthodontic assessmentFrom implant loading to 5-year follow-upNumber of prosthetic complications
Peri-implant bone heightFrom implant loading to 5-year follow-upMeasured on radiographs
Pocket probing depthFrom implant loading to 5-year follow-upPeri-implant probing depth
Chewing efficiencyFrom baseline to 5-year follow-uptwo-color mixing ability test

Countries

Switzerland

Contacts

Primary ContactSabrina Maniewicz
sabrina.maniewicz@unige.ch+4122 379 40 60

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026